Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Back
Association details:
Biomarker:
PTEN underexpression
Cancer:
Breast Cancer
Drug:
adavosertib (AZD1775)
(
WEE1 inhibitor
)
Direction:
Sensitive
Evidence:
Evidence Level:
Sensitive: D – Preclinical
New
Source:
Elife
Title:
PTEN and DNA-PK determine sensitivity and recovery in response to WEE1 inhibition in human breast cancer
Published date:
07/06/2020
Excerpt:
PTEN low' BLBCs were highly sensitive to AZD1775 and failed to recover following removal of AZD1775, while 'PTEN high' BLBCs recovered.
DOI:
10.7554/eLife.57894
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login